Carregant...
Improving the Angiogenic Potential of EPCs via Engineering with Synthetic Modified mRNAs
The application of endothelial progenitor cells (EPCs) for the revascularization of ischemic tissues, such as after myocardial infarction, stroke, and acute limb ischemia, has a huge clinical potential. However, the low retention and engraftment of EPCs as well as the poor survival of migrated stem...
Guardat en:
| Publicat a: | Mol Ther Nucleic Acids |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society of Gene & Cell Therapy
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6198099/ https://ncbi.nlm.nih.gov/pubmed/30343252 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omtn.2018.09.005 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|